Articles dans des revues avec comité de lecture (76)
  1. 48. Labranche, N., Youl, E., El Khattabi, C., Dewachter, L., Wauthoz, N., Delporte, C., Berkenboom, G., & Pochet, S. (2016). Rosuvastatin and vascular oxidative stress induced by diesel exhaust particles. Acta cardiologica, 71(5), 565 - 572. doi:10.2143/AC.71.5.3167500
  2. 49. Lenaerts, C., Bond, L., Tuytten, R., Delporte, C., Van Antwerpen, P., & Blankert, B. (2016). D3. Early prediction of preeclampsia risk assessment: analytical determination for marinobufagenin in pregnant women. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 29(sup2), 18. doi:10.1080/14767058.2016.1234778
  3. 50. Millán, L., Sampedro, M. C., Sanchez-Mazas, A., Delporte, C., Van Antwerpen, P., Goicolea, M. A., & Barrio, R. R. (2016). Liquid chromatography–quadrupole time of flight tandem mass spectrometry–based targeted metabolomic study for varietal discrimination of grapes according to plant sterols content. Journal of chromatography, 1454, 67-77. doi:10.1016/j.chroma.2016.05.081
  4. 51. Aldib, I., Gelbcke, M., Soubhye, J., Prévost, M., Furtmüller, P. G., Obinger, C., Elfving, B., Chikh Alard, I., Roos, G., Delporte, C., Berger, G., Dufour, D., Zouaoui Boudjeltia, K., Neve, J., Dufrasne, F., & Van Antwerpen, P. (2016). Novel bis-arylalkylamines as myeloperoxidase inhibitors: Design, synthesis, and structure-activity relationship study. European journal of medicinal chemistry, 123, 746-762. doi:10.1016/j.ejmech.2016.07.053
  5. 52. Noyon, C., Delporte, C., Dufour, D., Cortese, M., Rousseau, A., Poelvoorde, P., Neve, J., Vanhamme, L., Zouaoui Boudjeltia, K., Roumeguere, T., & Van Antwerpen, P. (2016). Validation of a sensitive LC/MSMS method for chloronucleoside analysis in biological matrixes and its applications. Talanta, 154, 322-328. doi:10.1016/j.talanta.2016.03.087
  6. 53. Soubhye, J., Aldib, I., Delporte, C., Prévost, M., Dufrasne, F., & Van Antwerpen, P. (2016). Myeloperoxidase as a Target for Treatment of Inflammatory Syndromes: Mechanisms and Structure Activity Relationships of Inhibitors. Current medicinal chemistry. doi:10.2174/0929867323666160607111806
  7. 54. Planinc, A., Bones, J., Dejaegher, B., Van Antwerpen, P., & Delporte, C. (2016). Glycan characterization of biopharmaceuticals: Updates and perspectives. Analytica chimica acta, 921, 13-27. doi:10.1016/j.aca.2016.03.049
  8. 55. Dawaliby, R., Trubbia, C., Delporte, C., Noyon, C., Ruysschaert, J. M., Van Antwerpen, P., & Govaerts, C. (2016). Phosphatidylethanolamine is a Key Regulator of Membrane Fluidity in Eukaryotic Cells. The Journal of biological chemistry, 291(7), 10.1074/jbc.M115.706523, 3658-67. doi:10.1074/jbc.M115.706523
  9. 56. Dawaliby, R., Trubbia, C., Delporte, C., Masureel, M., Van Antwerpen, P., Kobilka, B. K., & Govaerts, C. (2016). Allosteric regulation of G protein-coupled receptor activity by phospholipids. Nature Chemical Biology, 12(1), 1960, 35-39. doi:10.1038/nchembio.1960
  10. 57. Bromberg, L., Roufosse, F., Pradier, O., Delporte, C., Van Antwerpen, P., De Maertelaer, V., & Cogan, E. (2016). Methylprednisolone-induced lymphocytosis in patients with immune mediated inflammatory disorders. The American journal of medicine, 7(129), 746-752. doi:10.1016/j.amjmed.2016.02.013
  11. 58. Franck, T., Minguet, G., Delporte, C., Derochette, S., Zouaoui Boudjeltia, K., Van Antwerpen, P., Gach, O., Deby-Dupont, G., Mouithys-Mickalad, A., & Serteyn, D. (2015). An immunological method to combine the measurement of active and total myeloperoxidase on the same biological fluid, and its application in finding inhibitors which interact directly with the enzyme. Free radical research, 49(6), 790-799. doi:10.3109/10715762.2015.1027197
  12. 59. Millán Martín, S., Delporte, C., Farrell, A., McLoughlin, N., Bones, J., & Navas Iglesias, N. (2015). Comparative analysis of monoclonal antibody N-glycosylation using stable isotope labelling and UPLC-fluorescence-MS. Analyst, 140(5), 1442-1447. doi:10.1039/c4an02345e
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>